| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/05/2000 | EP1015604A1 Human prl-1 phosphatase |
| 07/05/2000 | EP1015602A1 Glutrna gln amidotransferase - a novel essential translational component |
| 07/05/2000 | EP1015593A1 Hepatitis b virus polypeptides |
| 07/05/2000 | EP1015592A1 $i(BACILLUS THURINGIENSIS) CRYET33 AND CRYET34 COMPOSITIONS AND USES THEREFOR |
| 07/05/2000 | EP1015590A2 Cyclin-dependent kinase inhibitors and uses thereof |
| 07/05/2000 | EP1015588A1 Cell growth regulator |
| 07/05/2000 | EP1015587A1 DcR3 POLYPEPTIDE, A TNFR HOMOLOG |
| 07/05/2000 | EP1015586A2 Tie receptor tyrosine kinase ligand homologues |
| 07/05/2000 | EP1015585A2 Tie ligand homologues |
| 07/05/2000 | EP1015583A2 Protein containing an srcr domain |
| 07/05/2000 | EP1015582A1 Breast cancer specific gene 1 |
| 07/05/2000 | EP1015578A1 Therapeutic molecules |
| 07/05/2000 | EP1015566A1 Human ste20-like stress activated serine/threonine kinase |
| 07/05/2000 | EP1015559A1 Human regeneration-associated serpin-1 (rasp-1) and methods of use |
| 07/05/2000 | EP1015496A2 Immuntoxins and methods of inducing immune tolerance |
| 07/05/2000 | EP1015495A2 Peptide sequences as hinge regions in proteins like immunoglobulin fragments and their use in medicine |
| 07/05/2000 | EP1015494A1 Catalytic antibodies and a method of producing same |
| 07/05/2000 | EP1015493A1 Novel epithelial tissue targeting agent |
| 07/05/2000 | EP1015492A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 07/05/2000 | EP1015481A1 Antigenic structural peptide, antigenic and immunogenic compounds and uses for detecting, preventing and treating an hcv infection |
| 07/05/2000 | EP1015477A1 32 human secreted proteins |
| 07/05/2000 | EP1015474A1 Don-1 gene and polypeptides and uses therefor |
| 07/05/2000 | EP1015473A1 CLONING AND EXPRESSION OF betaAPP-C100 RECEPTOR (C100-R) |
| 07/05/2000 | EP1015471A1 Hypoxia-regulated genes |
| 07/05/2000 | EP1015468A1 Follistatin-3 |
| 07/05/2000 | EP1015037A2 METHOD FOR INFLUENCING THE p53 LINKAGE IN TARGET GENES |
| 07/05/2000 | EP1015029A1 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent |
| 07/05/2000 | EP1015028A2 Methods to improve immunogenicity of antigens and specificity of antibodies |
| 07/05/2000 | EP1015021A2 Agents for combating bacterial meningitis |
| 07/05/2000 | EP1015016A1 Methods and compositions for preventing autoimmune disease |
| 07/05/2000 | EP1015009A1 Attenuated vif dna immunization cassettes for genetic vaccines |
| 07/05/2000 | EP0950062A4 Protein markers for esophageal cancer |
| 07/05/2000 | EP0853487B1 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 07/05/2000 | EP0794958A4 Pcr amplification of rearranged genomic variable regions of immunoglobulin genes |
| 07/05/2000 | EP0619839B1 Novel polypeptides for promoting cell attachment |
| 07/05/2000 | EP0577752B1 Human pf4a receptors and their use |
| 07/05/2000 | CN1259165A Modulators of intracellular inflamation, cell death and cell survival pathways containing a card and kinase domain |
| 07/05/2000 | CN1259141A PRRSV antigenic sites identifying peptide sequences of PRRS virus for use in vaccines or diagnostic assays |
| 07/04/2000 | US6084092 β(1-3)-glucan diagnostic assays |
| 07/04/2000 | US6084088 Polynucleotides encoding novel tumor antigens |
| 07/04/2000 | US6084087 Amino acid sequences; for diagnosis and treatment of rheumatoid arthritis; antiarthritic agents |
| 07/04/2000 | US6084084 Nucleotide and amino acid sequences; for anticonvulsants, neuroprotectants, analgesics and cognition enhancers; for diagnosis and therapy of related nervous system disorders |
| 07/04/2000 | US6084083 Amino acid sequence of polypeptide; for prognosis, diagnosis, monitoring, rational drug design, and/or therapeutic intervention of t helper cell related disorders including crohn's disease, lyme disease, insulin-dependent diabetes |
| 07/04/2000 | US6084075 Agonist and antagonist antibodies to the chemokine receptor-2 (CCR2) |
| 07/04/2000 | US6084067 CTLA4/CD28 ligands and uses therefor |
| 07/04/2000 | US6083924 DnaB of staphylococcus aureus |
| 07/04/2000 | US6083748 Antibodies which specifically bind to a novel κ/μ-like protein tyrosineospatase, PTPλ, and hybridoma cell lines producing the same |
| 07/04/2000 | US6083743 Dna and amino acid sequences; for diagnosis and treatment of infections including otitis media, epiglottitis, pneumonia, and tracheobronchitis; for immunogenic compositions/vaccines |
| 07/04/2000 | US6083724 Recombinant avian interferon-gamma (IFN-γ) |
| 07/04/2000 | US6083722 Borrelia antigen |
| 07/04/2000 | US6083713 Nucleotide sequences coding binding polypeptide for the terminal domain of the amyloid precursor protein; for the diagnosis and design of drugs for treatment of alzheimer's disease |
| 07/04/2000 | US6083708 Polypeptide: dendrimer complexes |
| 07/04/2000 | US6083707 Enzymatic peptide; for the detection of tumor propagation activity in cells, tissues and body fluids |
| 07/04/2000 | US6083705 Screening for chemical compound which preferentially binds to binding protein; incubation of compound with cells expressing binding protein, detecting preferential binding of compound to surface of cell not normally expressing binding protein |
| 07/04/2000 | US6083511 Isolated equine herpesvirus-4 (ehv-4) or gh or gc polypeptides and antigenic fragments; vaccine for the protection of horses against ehv-4 infection |
| 07/04/2000 | US6083504 Human monoclonal antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1) |
| 07/04/2000 | US6083502 Methods for detecting the antigen and its expression level as an indication of the presence of tumor cells |
| 07/04/2000 | US6083501 Drug for prevention and therapy of diseases caused by fibrinoid formation or thrombus formation in the lung and model animals of the diseases |
| 07/04/2000 | US6083478 Consists of a cytotoxic radionuclide and a homodimer comprising two heavy chains encoded by the expression vector designated cd4-igg2-pcdna1 (atcc no. 40952) |
| 07/04/2000 | US6083477 Useful therapeutic reagents for treating leukemias and lymphomas;conjugate of a non-immunogenic rnase or a therapeutic radionuclide that is an alpha-emitter or a beta-emitter and a cell-specific cytokine |
| 07/04/2000 | CA2103021C Recombinant dna coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence |
| 07/04/2000 | CA1341042C Y, & t cell receptor and methods for detection |
| 06/29/2000 | WO2000037648A1 Protective antigen of group a streptococci (spa) |
| 06/29/2000 | WO2000037646A2 Group b streptococcus proteins, and their use |
| 06/29/2000 | WO2000037643A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 06/29/2000 | WO2000037640A2 Compositions and methods for the treatment of tumor |
| 06/29/2000 | WO2000037639A2 Lymphocytic membrane proteins |
| 06/29/2000 | WO2000037638A2 Methods and compositions for inhibiting neoplastic cell growth |
| 06/29/2000 | WO2000037632A1 Monoclonal antibody against apolipoprotein a-i |
| 06/29/2000 | WO2000037613A2 Human akt-3 |
| 06/29/2000 | WO2000037612A1 SOMATIC CELLS WITH ABLATED Prp GENE AND METHODS OF USE |
| 06/29/2000 | WO2000037504A2 Human monoclonal antibodies to ctla-4 |
| 06/29/2000 | WO2000037503A1 Compositions and methods for generating monoclonal antibodies representative of a specific cell type |
| 06/29/2000 | WO2000037502A2 Vascular endothelial cell growth factor antagonists and uses thereof |
| 06/29/2000 | WO2000037494A2 Chlamydia trachomatis antigens |
| 06/29/2000 | WO2000037493A2 Type iii secretion system antigens from bordetella pertussis |
| 06/29/2000 | WO2000037491A2 Dnas encoding proteins with signal sequences |
| 06/29/2000 | WO2000037490A2 Outer surface proteins, their genes, and their use |
| 06/29/2000 | WO2000037483A1 Protein-protein interactions in neurodegenerative disorders |
| 06/29/2000 | WO2000037107A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
| 06/29/2000 | WO2000037105A2 Streptococcus pneumoniae proteins and immunogenic fragments for vaccines |
| 06/29/2000 | WO2000037102A2 Improvement of tolerance to a xenograft |
| 06/29/2000 | WO2000037025A2 Antibodies to truncated vegf-d and uses thereof |
| 06/29/2000 | WO2000012113A3 Method of modulating memory effector t-cells using a cd2-binding agent, and compositions |
| 06/29/2000 | WO2000008180A3 HUMAN cDNAs ENCODING POLYPEPTIDES HAVING KINASE FUNCTIONS |
| 06/29/2000 | WO2000006737A3 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 06/29/2000 | WO2000006717A3 Improved transformation efficiency in phage display through modification of a coat protein |
| 06/29/2000 | WO2000006605A3 Heterominibodies |
| 06/29/2000 | WO2000004861A8 Agents that bind to and inhibit human cytochrome p450 2a6 |
| 06/29/2000 | WO2000001817A3 Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods |
| 06/29/2000 | WO2000000610A3 Human signal peptide-containing proteins |
| 06/29/2000 | WO2000000594A3 Human transferases |
| 06/29/2000 | WO1999067415A9 Novel molecules of the t110-related protein family and uses thereof |
| 06/29/2000 | WO1999064627A8 Probes used for genetic profiling |
| 06/29/2000 | WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 06/29/2000 | WO1999049019A3 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics |
| 06/29/2000 | CA2619682A1 Human monoclonal antibodies to ctla-4 |
| 06/29/2000 | CA2450402A1 Methods and compositions for inhibiting cancer cell growth comprising pro224 |
| 06/29/2000 | CA2358086A1 Protein-protein interactions in neurodegenerative disorders |
| 06/29/2000 | CA2356987A1 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |